Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004927 · ClinicalTrials.gov registry record · Phase 1
BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
A Phase 1 study, sponsored by R-Pharm.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004927: Completed Phase 1 study, sponsored by R-Pharm.
NCT00004927 is a Phase 1 study that has completed, run by R-Pharm. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004927, a Phase 1 study, has completed, sponsored by R-Pharm.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
Interventions
- DRUG ixabepilone
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-07 |
| Est. Completion | 2002-10 |
| Phase | Phase 1 |
What the finished NCT00004927 record still lists
NCT00004927 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which ixabepilone is the first listed.
NCT00004927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004927 about?
NCT00004927 is a clinical study titled "BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
What is the current status of trial NCT00004927?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-07. Estimated completion is 2002-10.
What interventions are being tested in trial NCT00004927?
The interventions under investigation include: ixabepilone (DRUG).
Who is sponsoring clinical trial NCT00004927?
This trial is sponsored by R-Pharm, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia